Division of Anaesthesiology
Geneva, Switzerland
NCT Number: NCT06131892
Hypothermia (core temperature ≤35°C) is a frequent and life-threatening complication after mountain accidents, near-drowning, and intoxications, and can provoke arrhythmia, reduced cardiac contractility, and cardiac arrest. The hypothermic heart may be insensitive to defibrillation with a core temperature <30°C. Also, below <30°C after successful defibrillation, a perfusing rhythm often degenerates to ventricular fibrillation (VF) again. Repeated defibrillation can induce myocardial injury. Thus, the guidelines of the European Resuscitation Council (ERC) suggest delaying further defibrillation attempts until the core temperature is >30°C if VF persists after 3 shocks. Epinephrine should be withheld if core temperature is <30°C. Advanced Life Support (ALS) guidelines of the American Heart Association (AHA) state that it may be reasonable to perform further defibrillation attempts according to the standard algorithm and to consider administration of a vasopressor during cardiac arrest (Table 1). This discrepancy between ERC and AHA guidelines can be explained by the different interpretations of mainly animal data, which show that vasopressors increase the chances of successful defibrillation <30°C, defined as return of spontaneous circulation (ROSC) for at least 30 seconds. The guidelines of the Wilderness and Environmental Medicine Society (WMS) state that a single shock at a maximum power can be given for patients with a temperature <30°C.
The aim of this study is to evaluate clinical course of hypothermic patients(<30°C) undergoing defibrillation. The primary aim is to evaluate the success ratio of defibrillation, defined as ROSC for at least 30 seconds. Secondary aims are the recurrence rate of ventricular fibrillation, the number of defibrillation attempts per patient, the presence of cardiac dysfunction after defibrillation and the cerebral performance category (CPC) score at the end of hospitalization.
Looking for future studies?
Notify MeAll sexes
Observational
Geneva, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Defibrillation
Time frame: through study completion, an average of 3 months
Time frame: through study completion, an average of 3 months
Time frame: through study completion, an average of 3 months
Time frame: through study completion, an average of 3 months
a decrease in cardiac output, or a reduced ejection fraction, systolic or diastolic dysfunction on echocardiographic ultrasound
Time frame: through study completion, an average of 3 months
a score from 1 to 5, with "1" meaning "Good Outcome", "5" means dead
University Hospital, Geneva
Other
Defibrillation in Accidental Hypothermia: a Retrospective Study of the International Hypothermia Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05409560
Body Temperature Changes, Cold Water Swimming
Caen, France
View Trial DetailsNCT05469958
Body Temperature Changes, Hypothermia
Sant Cugat del Vallès, Barcelona-CATALUNYA, Spain
View Trial DetailsNCT05908630
Body Temperature Changes, Cardiovascular Diseases
Næstved, Region Sjælland, Denmark
View Trial DetailsNCT04935632
Body Temperature Changes, Hypothermia
Lyon, Rhone, France
View Trial Details